Mouse TNF-α enzyme-linked immunoassay kit
| Specification | 96 Test |
|---|---|
| Sensitivity | 0.097 pg/ml (10 μl) |
| Standard Curve Range | 1.37~1000 pg/ml |
| Standard Curve Gradient | 7 Points/3 Folds |
| Number of Incubations | 2 |
| Detectable sample | Liquid phase sample of soluble substances. For example: serum, plasma, cell culture supernatant, tissue grinding liquid, etc. |
| Sample Volume | 10 μl |
| Type | Fully Ready-to-Use |
| Operation Duration | 120min |
| pg/ml | O.D. | Average | Corrected | |
|---|---|---|---|---|
| 0 | 0.0121 | 0.0111 | 0.0116 | |
| 1.37 | 0.0242 | 0.0223 | 0.0233 | 0.0117 |
| 4.12 | 0.0482 | 0.0444 | 0.0463 | 0.0347 |
| 12.35 | 0.1134 | 0.1092 | 0.1113 | 0.0997 |
| 37.04 | 0.3165 | 0.3032 | 0.3099 | 0.2983 |
| 111.11 | 0.8042 | 0.7996 | 0.8019 | 0.7903 |
| 333.33 | 1.9672 | 1.9564 | 1.9618 | 1.9502 |
| 1000 | 4.1683 | 4.2715 | 4.2199 | 4.2083 |
Precision
| Intra-assay Precision | Inter-assay Precision | |||||
| Sample Number | S1 | S2 | S3 | S1 | S2 | S3 |
| 22 | 22 | 22 | 6 | 6 | 6 | |
| Average(pg/ml) | 16.1 | 80.4 | 271.7 | 14 | 75.2 | 236.7 |
| Standard Deviation | 1.1 | 4.8 | 16 | 0.3 | 4 | 10.8 |
| Coefficient of Variation(%) | 6.5 | 5.9 | 5.9 | 2 | 5.3 | 4.6 |
Intra-assay Precision (Precision within an assay) Three samples of known concentration were tested Twenty-two times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays) Three samples of known concentration were tested six times on one plate to assess intra-assay precision.
Spike Recovery
The spike recovery was evaluated by spiking 3 levels of mouse TNF alpha into mouse serum sample. The un-spiked serum was used as blank in this experiment.
The recovery ranged from 107% to 132% with an overall mean recovery of 116%.
Sample Values
| Sample Matrix | Sample Evaluated | Range (pg/ml) | Detectable (%) | Mean of Detectable (pg/ml) |
|---|---|---|---|---|
| Serum | 30 | n.d.-0.28 | 33 | 0.16 |
Serum/Plasma – Thirty samples from apparently healthy mice were evaluated for the presence of TNF alpha in this assay. No medical histories were available for the donors.
n.d. = non-detectable. Samples measured below the sensitivity are considered to be non-detectable.
Product Data Sheet
Background: TNF-α
Tumor necrosis factor alpha (TNF-alpha ), also known as cachectin and TNFSF1A, is the prototypic ligand of the TNF superfamily. It is a pleiotropic molecule that plays a central role in inflammation, immune system development, apoptosis, and lipid metabolism. TNF-alpha is also involved in a number of pathological conditions including asthma, Crohn's disease, rheumatoid arthritis, neuropathic pain, obesity, type 2 diabetes, septic shock, autoimmunity, and cancer.
Mouse TNF-alpha is synthesized as a 26 kDa type II transmembrane protein that consists of a 35 amino acid (aa) cytoplasmic domain, a 21 aa transmembrane segment, and a 179 aa extracellular domain (ECD). Within the ECD, mouse TNF-alpha shares 95% aa identity with rat, and 80% aa identity with canine, equine, feline, human, rabbit, and porcine TNF-alpha. It is produced by a wide variety of immune, epithelial, endothelial, and tumor cells. TNF-alpha is assembled intracellularly to form a noncovalently linked homotrimer which is expressed on the cell surface. Cell surface TNF-alpha can both induce the lysis of tumor cells and virus infected cells, and generate its own downstream cell signaling following ligation by soluble TNF RI. Shedding of membrane bound TNF-alpha by TACE/ADAM17 releases the bioactive cytokine, a 55 kDa soluble trimer containing the TNF-alpha extracellular domain.
TNF-alpha binds the ubiquitous 55-60 kDa TNF RI and the hematopoietic cell-restricted 78-80 kDa TNF RII, both of which are also expressed as homotrimers. Both type I and type II receptors bind TNF-alpha with comparable affinity and can promote NFkB activation. Only TNF RI, however, contains a cytoplasmic death domain which triggers the activation of apoptosis. Soluble forms of both types of receptors are released into human serum and urine, and can neutralize the biological activity of TNF.
Under construction!
Under construction!
Under construction!
Citations
-
(−)-Epicatechin gallate prevented atherosclerosis by reducing abnormal proliferation of VSMCs and oxidative stress of AML 12 cells
Applications: ELISA
Reactivity: Mouse
Publish Date: 2024 Jul
-
Luteolin attenuates RA-associated chronic pain by targeting the LDHA/H3K9la/NFATC2 axis to suppress Th17 cell differentiation and central infiltration
Applications: ELISA
Reactivity: Mouse
Publish Date: 2025 Jun
-
Harmine derivative ZLWH-38 ameliorates the therapeutic efficacy of colistin against XDR-Ab pneumonia by suppressing inflammatory responses
Applications: ELISA
Reactivity: Mouse
Publish Date: 2025 Sept
-
Lipocalin 2 deficiency attenuates NLRP3 inflammasome activation through glycolysis impairment and MGST1-mediated mitochondrial ROS reduction
Applications: ELISA
Reactivity: Mouse
Publish Date: 2025 Nov
-
An antibacterial, antioxidant and hemostatic hydrogel accelerates infectious wound healing
Applications: ELISA
Reactivity: Mouse
Publish Date: 2025 Jan
-
Recombinant human collagen XVII promotes skin repair and regeneration by upregulating Lgr6 signaling pathway
Applications: ELISA
Reactivity: Mouse
Publish Date: 2025 Dec
-
Phytochemicals From Hansenia weberbaueriana for Psoriasis and Inflammatory Bowel Disease Comorbidity: Based on Network Pharmacology and In Vitro Analysis
Applications: ELISA
Reactivity: Mouse
Publish Date: 2025 Oct
-
METTL3-mediated m6A on nascent RNA coordinates translational and transcriptional programs to activate the NLRP3 inflammasome in macrophages
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Jan
-
Investigating the role of SMOX in rheumatoid arthritis
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Jan
-
Functional Restoration of Uterine Architecture and Fertility via a 3D-Printed Biomimetic Scaffold: The Role of Macrophage-Driven Immunomodulation
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Feb
-
A novel DYRK1A inhibitor alleviates lipopolysaccharide-induced acute lung injury via suppressing inflammatory pathway
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Feb
-
Colonic Engyodontium fungus triggers neutrophil antimicrobial activity to suppress Lactobacillus johnsonii-derived glutamic acid-maintained Tregs
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Mar
-
TRIM21 Exacerbates Ischemic Brain Injury by Promoting Astrocyte-Mediated Neuroinflammation via K63-Linked Ubiquitination of MDA5
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Mar
-
Abolishing PorB-induced mitophagy enhances gonococcal outer membrane vesicle vaccine efficacy
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Mar
-
Engineered M2 macrophage-derived vesicles deliver DNase I for cfDNA clearance and multi-organ protection in sepsis
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Mar
-
Mechanistic study of swertiamarin in treating ulcerative colitis by regulating YAP-mediated Wnt and Notch pathways for intestinal stem cell repair
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Mar
-
Temporally Programmed and Laser-Triggered Immunomodulatory Hydrogel Enables Synergistic Wound Healing and Prevention of Postoperative Tumor Recurrence
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Apr
-
Ginsenoside compound K up-regulates β-subunits of long-chain L-3-hydroxyacyl-CoA (HADHB) to promote fatty acid oxidation recovery and improve the balance of macrophage polarization in mice with ulcerative colitis
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Apr
-
Gut microbial metabolite indole-3-acetic acid inhibits microglia-mediated synaptic loss in Alzheimer’s disease by targeting CCR4
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Apr
-
Hexokinase 3 promoted cytokine production of monocytes by targeting metabolic reprogramming and histone lactylation in sepsis
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Apr
-
Erbin Confers Neuroprotection Against Cerebral Ischemia-Reperfusion Injury in Mice via MAPK Pathway Inhibition
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Apr
-
Maternal obesity induces macrophage to myofibroblast transition in kidneys of male offspring through a pathway driven by 20-hydroxyeicosatetraenoic acid
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 May
-
Sleep deprivation induces anxiety-like behaviors through IL-6 driven astrocyte-GABAergic neuron crosstalk in the PAG-ACC circuit
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 May
-
A combination nano-immunotherapy targeting cholesterol crystals and STING signaling enhanced disrupts atherosclerotic plaque pathogenesis
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 May
-
pH-switchable palladium nanozymes deliver GSH-scavenging α-bromocinnamaldehyde for MRSA-infected wound healing
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 May
-
Peroxidase-Enriched Extracellular Vesicles from Ginkgo biloba Ameliorate Acute Lung Injury via ROS Scavenging, M2 Macrophage Polarization and Barrier Protection
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 May
-
Imaging Study of MnO2-Based Nanomotors Modulating HIF-1α/Lipid Droplet Biogenesis and Activating the cGAS-STING Pathway
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 May
-
Sinomenine Regulates PSMB9 to Mediate Therapeutic Effects in Rheumatoid Arthritis
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 May
-
Fusobacterium nucleatum-derived succinic acid aggravates colitis by triggering macrophage pro-inflammatory phenotypic transformation via SUCNR1/NF-κB axis
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Jul
-
Sodium Danshensu alleviates oxidative stress-induced endothelial apoptosis and senescence by modulating the SIRT1/p53 pathway
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Jul
-
hUC-MSCs via β-NGF Alleviate Cognitive Impairment After Tibial Fracture Surgery by Regulating the STMN2/NMNAT2-SARM1-NF-κB Signaling Pathway
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Jul
-
Targeting CD8+ T cell-derived granzyme K alleviates radiation-induced pulmonary fibrosis by attenuating senescence and SASP
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Jul
-
Targeted eradication of Fusobacterium nucleatum biofilms to reverse tumor immunosuppression and inhibit E-cadherin/β-catenin signaling for colorectal cancer therapy
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Feb
-
Strontium-incorporated thermoresponsive hydrogel platform co-delivering graphene oxide-mannose nanocomplexes: An osteoimmunomodulatory strategy for periodontitis therapy
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Aug
-
IDO1 Inhibitor RY103 Prevents Sepsis-Associated Immunosuppression in Cecal Ligation and Puncture Mice
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Aug
-
Comparative Analysis of LPS/IFN-γ and LPS/ATP-Induced Inflammatory Models in BV2 Microglia
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Aug
-
Brassica rapa L. (Turnip) Ethanol Extract Alleviates Hyperuricemia by Modulating Purine Metabolism Enzymes and Renal Urate Transporters
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Sept
-
Bifidobacterium longum Subspecies infantis M63 Enhances the Colitis-Alleviating Effect of 2′-Fucosyllactose by Restoring Intestinal Barrier Function and Microbial Metabolism
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Sept
-
Hemolytic mechanism and virulence of Antarctic psychrophilic Pseudomonas
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Sept
-
Therapeutic Potential of Thiosemicarbazone Derivative in LPS‐Induced Mastitis: Dual Modulation of Inflammatory Response and Blood–Milk Barrier Integrity
Applications: ELISA
Reactivity: Mouse
Publish Date: 2026 Sept
